Sanders Accused of Targeting Pharma CEOs for Drug Price Lawsuits

Johnson & Johnson is accusing Sen. Bernie Sanders (I-Vt.) of retaliating against the company and others that sued the Biden administration to stop a program to negotiate how much Medicare pays for high-cost drugs.

The allegation appears in a letter obtained by Bloomberg Law and follows a Senate Health, Education, Labor and Pensions (HELP) Committee announcement that it would vote on whether it would use subpoenas to force CEOs from J&J and Merck & Co. to testify on US drug prices.

The committee’s actions raise “significant concerns that the hearing is intended as retribution” against companies that are suing ...